4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-038663
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir Director | 2018-06-15 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…